Cannabis went crazy in 2018.
Veritas Pharma (VRT.C) moved further along the trail to commercialization when the company announced that it is currently working with its research arm, Cannevert Therapeutics to design and implement the first clinical trials of cannabis strains targeting pain.
Rapidly growing US weed player Marapharm (MDM.C) has been taking full advantage of the several million in cash they’ve brought in from warrants of late, building out a 360k sq ft grow facility in Las Vegas, and this week announcing that they’re taking a position in Vancouver cannabis research outfit, Veritas Pharma (VRT.C).
Biotech research outfit Veritas Pharma (VRT.C), which has locked up a multitude of big academics as it seeks to lock down the best strains to deal with pain and nausea, has taken a step into locking down its future by signing an LOI to acquiring Sechelt Organic Marijuana.
First off, big welcome to any VancouverIsAwesome folk who have found their way over to our humble abode via my new weekly column Investing is Awesome.
Veritas Pharma (VRT.C), the medical marijuana research stock that took a two week hit as a large investor dumped his stock to market, rebounded fully today on a day of big buying that saw the stock return to its several month average.
Yesterday, I wrote a quick story about how Veritas Pharma (VRT.C) had jumped 15% or so after a mild sell-off the week before. By the time I’d posted it, VRT had reversed that jump and slid another 10% or so. I considered changing the story to reflect the change, but the moves were on small volume and could have swung the other way again in a single trade, so it just seemed like the best thing to do was throw hands up and move on.
When I was running the editorial show at Stockhouse, I had reason to look over a lot of messageboards for a wide variety of public companies. Almost without fail, you could bet that any given messageboard would be faced with two problems.
Last December, Canadian Liberal Party mover/shaker, founding partner in Canopy Growth Corporation (CGC.V) and private equity player Chuck Rifici bought Wikileafs, the best named dispensary price comparison app out there, for an undisclosed sum, through his Nesta Holding Company,
Medicinal cannabis research startup Veritas Pharmaceuticals (VRT.C) had a good day Tuesday when they received approval from Health Canada to legally perform cannabis research.
In our latest podcast, Dr. Lui Franciosi has chops in the pharma game, but the collection of professors emeritus, leaders in biochemistry, cancer research gods, and generally cleverer-than-me smartypants’ he’s put together at Veritas Phrama (VRT.C) is something to behold.